Dr. Megson was awarded the Sir James Black young investigator award at the November 1996 meeting of the Scottish Society of Experimental Medicine. This manuscript is a brief review of the work presented at the meeting.
LangfordEJ, BrownAS, WainwrightRJ, De BeiderAJ, ThomasMR, SmithREA, RadomskiMW, MartinJF, MoncadaS. Inhibition of platelet activity by S-nitrosoglutathione during coronary angioplasty. Lancet1994; 344: 1458–60.
3.
HeG-W, BuxtonB, RosenfeldtFL, AngusJA. Reactivity of human isolated internal mammary artery to constrictor and dilator agents: Implications for treatment of internal mammary artery spasm. Circulation1989; 80 (suppl): 1141–50.
4.
IgnarroLJ, LipptonH, EdwardsJC, BaricosWH, HymanAL, KadowitzPJ, GreutterCA. Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: Evidence for the involvement of Snitrosothiols as active intermediates. J Pharmacol Exp Ther1981; 218: 739–49.
5.
HardmanJG, LimbirdLE, MolinoffPB, RuddonRW, GilmanAG, editors. Goodman & Gilman's The Pharmacological Basis of Disease. 9 ed.New York: McGraw-Hill, 1996.
ButlerAR, GlidewellC. Recent chemical studies of sodium nitroprusside relevant to its hypotensive action. Chem Soc Rev1987; 16: 361–80.
8.
KowalukEA, SethJ, Fung H-L. Metabolic activation of sodium nitroprusside to nitric oxide in vascular smooth muscle. J Pharmacol Exp Ther1992; 262: 916–22.
9.
BauerJA, FungHL. Differential hemodynamic effects and tolerance properties of nitroglycerin and an S-nitrosothiol in experimental heart failure. J Pharmacol Exp Ther1991; 256: 249–54.
10.
StamlerJS, JarakiO, OsborneJ, SimonDI, KeaneyJ, VitaJ, SingelD, ValeriCR, LoscalzoJ. Nitric oxide circulates in mammalian plasma primarily as an S-nitroso adduct of serum albumin. Proc Natl Acad Sci USA1992; 89: 7674–77.
11.
De BeiderAJ, MacAllisterR, RadomskiMW, MoneadaS. Effects of S-nitrosoglutathione in the human forearm circulation: Evidence for selective inhibition of platelet activation. Cardiovasc Res1994; 28: 691–94.
12.
MacAllisterRJ, CalverAL, RiezebosJ, CollierJ, VallanceP. Relative potency of nitrovasodilators on human blood vessels: An insight into the targeting of nitric oxide delivery. J Pharmacol Exp Ther1995; 273: 1529–37.
13.
DicksAP, SwiftHR, WilliamsDLH, ButlerAR, Al-Sa'doniHH, CoxBG. Identification of Cu+ as the effective reagent in nitric oxide formation from S-nitrosothiols (RSNO). J Chem Soc Perkin Trans 21996:481–87.
14.
AskewSC, ButlerAR, FlitneyFW, KempGD, MegsonIL. Chemical mechanism underlying the vasodilator and platelet anti-aggregating properties of S-nitroso-N-acetyl-D, L-penicillamine and S-nitrosoglutathione. Bioorg Med Chem1995; 3: 1.
15.
FlitneyFW, MegsonIL, FlitneyDE, ButlerAR. Iron-sulphur cluster nitrosyls, a novel class of nitric oxide generator: Mechanism of vasodilator action on rat isolated tail artery. Br J Pharmacol1992; 107: 842–48.
16.
MegsonIL, GreigIR, ButlerAR, GrayGA, WebbDJ. Vasodilator properties of a novel nitrosated glyco-arnino acid in isolated rat femoral arteries: Potential as a slow release nitric oxide donor drug. Br J Pharmacol1997;in press.
